Similar articles

• Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.

  Jähnchen E, Meinertz T, Gilfrich HJ, Groth U. Jähnchen E, et al. Eur J Clin Pharmacol. 1976 Sep 30;10(5):349-56. doi: 10.1007/BF00565625. Eur J Clin Pharmacol. 1976. PMID: 61862
• Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.

  Lai CM, Levy G. Lai CM, et al. J Pharm Sci. 1978 Oct;67(10):1492-3. doi: 10.1002/jps.2600671053. J Pharm Sci. 1978. PMID: 81299 No abstract available.
• Interaction of phenylbutazone and tolbutamide in man.

  Szita M, Gachályi B, Tornyossy M, Káldor A. Szita M, et al. Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):378-80. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 7450929
• [Conditions for the occurrence of drug interactions during biotransformation].

  Grille W, Johnsen K, Kolenda KD. Grille W, et al. Med Klin. 1979 Jan 19;74(3):55-67. Med Klin. 1979. PMID: 83532 Review. German. No abstract available.
• ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].

  Balant L. Balant L. Diabete Metab. 1978 Jun;4(2):135-43. Diabete Metab. 1978. PMID: 98364 Review. French. No abstract available.